Taking stock of the drug industry, from the lab to the medicine chestMarch 23, 2023Check out STAT+Sponsored ByBy Ed SilvermanPharmalot Columnist, Senior Writer PAL PILLAI/AFP/Getty Images STAT+ | J&J loses a patent battle in India over a crucial tuberculosis drug Several Indian companies are said to be ready to make a generic version of the J&J drug later this year, according to Doctors Without Borders By Ed Silverman STAT+ | Key senators blast Medicare Advantage insurers for 'exorbitant salaries,' 'massive payouts' to execs Sens. Elizabeth Warren and Jeff Merkley are blasting Medicare Advantage insurers over "massive payouts" to execs and shareholders. By John Wilkerson Listen: Bancel v. Bernie, Sarepta's FDA runaround, & Regeneron's ever-growing blockbuster We discuss the merits and actual implications of Moderna CEO Stéphane Bancel's appearance before a committee led by Sen. Bernie Sanders. By Damian Garde and Meg Tirrell Drew Angerer/Getty Images Former surgeon general Jerome Adams tries to outrun the shadow of the president he served Adams discussed communicating about science and health in these politically divisive times and escaping the shadow of Donald Trump. By Usha Lee McFarling Tuberculosis cases nearly back to pre-pandemic levels, data show Though humans have suffered from this disease for centuries, it is not top of mind, even among health care providers, in the modern era. By Helen Branswell More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments